Bhaskar Chaudhuri Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Bhaskar Chaudhuri is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 867,826 shares of ARQT, which is worth approximately $13.4 Million. The most recent transaction as insider was on Jun 12, 2025, when has been sold 7,609 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 868K

0.88% 3M change

0.88% 12M change

Total Value Held $13.4 Million

BHASKAR CHAUDHURI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2025	BUY Grant, award, or other acquisition	-	7,609 Added 0.87%	867,826 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,139 Added 1.16%	860,217 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	4,375 Added 0.51%	850,078 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	4,312 Added 0.51%	845,703 Common Stock
Jun 25 2021	SELL Open market or private sale	$185,762 $27.5 p/Share	6,755 Reduced 0.8%	841,391 Common Stock
Jun 24 2021	SELL Open market or private sale	$20,048 $27.5 p/Share	729 Reduced 0.09%	848,146 Common Stock
Jun 21 2021	SELL Open market or private sale	$69,190 $27.5 p/Share	2,516 Reduced 0.3%	848,875 Common Stock
Jun 01 2021	SELL Open market or private sale	$275,000 $27.5 p/Share	10,000 Reduced 1.16%	851,391 Common Stock
Apr 20 2021	SELL Open market or private sale	$282,600 $28.26 p/Share	10,000 Reduced 1.15%	861,391 Common Stock
Mar 22 2021	SELL Open market or private sale	$311,000 $31.1 p/Share	10,000 Reduced 1.13%	871,391 Common Stock
Feb 22 2021	SELL Open market or private sale	$356,600 $35.66 p/Share	10,000 Reduced 1.12%	881,391 Common Stock
Feb 01 2021	SELL Open market or private sale	$330,804 $33.25 p/Share	9,949 Reduced 1.1%	891,391 Common Stock
Jan 29 2021	SELL Open market or private sale	$1,402 $27.5 p/Share	51 Reduced 0.01%	901,340 Common Stock

Also insider at

TLGTQ

Teligent, Inc. Healthcare

Director

TARS

Tarsus Pharmaceuticals, Inc. Healthcare

Director